Rapid Automated Antibody Purification Using Protein A-Coupled Magnetic Beads With Andrew+

Importance of the Topic

Monoclonal antibodies represent one of the fastest-growing categories of biopharmaceuticals, driving demand for high-throughput, small-scale purification methods that integrate seamlessly with miniaturized bioreactor workflows. High-purity antibody samples are essential for downstream characterization and quality control, and magnetic bead–based affinity capture offers a user-friendly approach without complex hardware.

Objectives and Study Overview

This study introduces a fully automated antibody purification protocol based on Protein A-coupled magnetic beads implemented on the Andrew+ pipetting robot. The workflow is designed to process eight samples in 35 minutes, accommodate a wide range of antibody titers (0.2–1.5 µg/µL), and adjust load capacity (20–180 µg) to deliver concentrated or standard-strength eluates as required.

Methodology and Instrumentation

Samples of clarified cell culture media were incubated with Protein A magnetic beads in binding buffer, followed by sequential washes and acidic elution. Key hardware included:

• Andrew+ pipetting robot with domino positioning and microplate gripper
• 96-well PCR Magnet+ plate for bead capture
• Microplate Shaker+ set at 1,350 rpm for 5 min to maintain bead suspension
• ACQUITY UPLC H-Class Bio System with BEH SEC column (4.6×150 mm, 1.7 µm) and TUV detection at 220/280 nm
• Empower 3 software for data acquisition and SEC analysis

Key Results and Discussion

The automated protocol consistently achieved over 75% antibody recovery across 20–180 µg loads with RSD ≤10%. Compared with a semi-automated platform requiring ~80 min for eight samples, Andrew+ completed purification in 35 min with no manual steps. Robustness testing demonstrated stable yields when bead slurry volume varied ±10% and elution buffer pH ranged from 2.0 to 3.0. Low-titer samples were concentrated via multiple loading cycles, while high-titer loads benefited from extended (10 min) binding to boost recovery from 65% to 87%.

Benefits and Practical Applications

• Hands-free capture and elution streamline biotherapeutic development and QC.
• Rapid processing increases throughput for early-stage screening.
• Flexible protocols adapt to diverse titer ranges and sample volumes.
• Compatibility with downstream UPLC-SEC analysis ensures seamless data integration.

Future Trends and Applications

Automated magnetic bead purification is poised to integrate with online LC-MS workflows, enabling real-time process monitoring. Advances in bead chemistries and AI-driven protocol optimization may further enhance binding kinetics and reduce reagent consumption. Scalable robots could support larger-scale process development and Good Manufacturing Practice (GMP) environments.

Conclusion

The Andrew+-driven, Protein A magnetic bead protocol offers a reproducible, robust, and fully automated solution for high-throughput antibody purification. With >75% recovery, minimal manual intervention, and adaptability to varying sample titers, this workflow accelerates biotherapeutic research and quality control.

References

1. Choe W, Durgannavar TA, Chung SJ. Fc-Binding Ligands of Immunoglobulin G: An Overview of High Affinity Proteins and Peptides. Materials. 2016;9:994.
2. Brechmann NA, Eriksson P, Eriksson K, et al. Pilot-Scale Process for Magnetic Bead Purification of Antibodies Directly From Non-Clarified CHO Cell Culture. Biotechnol Prog. 2019;35(3):1-10.
3. Kuhn E, Fabbami L, van der Heuvel Z, et al. Automation of the Multiplexed Peptide Immune-MRM-MS Workflow on Bravo AssayMAP Platform. Broad Institute and Agilent Technologies.
4. GE Healthcare. Antibody Purification Handbook. GE Healthcare.
5. Promega Corporation. Magne Protein A Beads and Magne Protein G Beads for Antibody Purification. 2015.
6. Bratz M, Godat B, Wieczorek D, Nath N. A Robust High-Throughput Method for Antibody Purification using Magnetic Beads on the KingFisher Flex Platform. Promega Corporation; 2016.
7. Li F, Vijayasankaran N, Shen A, Kiss R, Amanullah A. Cell Culture Processes for Monoclonal Antibody Production. mAbs. 2010;2(5):466-477.